Emerging data suggest Retatrutide , a dual activator targeting both GLP-1 and GIP , appears to provide a significant step forward for weight loss . Early human trials have shown impressive losses in https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026